Press release
Deadline on Sept 27th upcoming in Lawsuit for Investors in Oasmia Pharmaceutical AB (publ) (NASDAQ: OASM)
A Deadline is coming up on September 27, 2019 in the lawsuit for certain investors in Oasmia Pharmaceutical AB (publ).
Investors who purchased shares of Oasmia Pharmaceutical AB (publ) (NASDAQ: OASM) have certain options and there are strict and short deadlines running. Deadline: September 27, 2019. NASDAQ: OASM stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Eastern District of New York the plaintiff alleges on behalf of purchasers of Oasmia Pharmaceutical AB (publ) (NASDAQ: OASM) common shares between October 23, 2015 through July 9, 2019, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between October 23, 2015 through July 9, 2019, the defendants made false and/or misleading statements and/or failed to disclose that Oasmia engaged in improper related-party transactions with Alceco International S.A. and Ardenia Investment LTD, which were controlled by Defendant Aleksov and his former father-in-law, that due to those transactions, millions of Swedish kronor were not accounted for in Oasmia's books;, that transactions concerning Oasmia's patents were also "carried out in a doubtful way;" and that as a result of the aforementioned misconduct, defendants' statements about Oasmia's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
Those who purchased shares of Oasmia Pharmaceutical AB (publ) (NASDAQ: OASM) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on Sept 27th upcoming in Lawsuit for Investors in Oasmia Pharmaceutical AB (publ) (NASDAQ: OASM) here
News-ID: 1831690 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Oasmia
Paclitaxel Micelles Market Size, Share and Forecast By Key Players-Oasmia Pharma …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Paclitaxel Micelles market is anticipated to grow at a compound annual growth rate (CAGR) of 10.61% between 2024 and 2031. The market is expected to grow to USD 8.84 Billion by 2024. The valuation is expected to reach USD 17.91 Billion by 2031.
The market for Paclitaxel Micelles is expanding significantly as a result of the increased incidence of cancer in the…
Women Health Therapeutics Market : Ready To Fly on high Growth Trends | Oasmia, …
The Women Health Therapeutics Market research report represents major insights on the current growth dynamics as well as the primary revenue generation elements that are available in the Women Health Therapeutics industry along with various other factors over the predicted period 2023-2030. The report on the Public Relations Service market is focusing on a series of parameters including top manufacturing strategies, industry share, prime opportunities, industrial channels, profit margin, etc.…
Lawsuit filed for Investors in shares of Oasmia Pharmaceutical AB (publ) (NASDAQ …
An investor, who purchased shares of Oasmia Pharmaceutical AB (publ) (NASDAQ: OASM), filed a lawsuit in the U.S. over alleged violations of Federal Securities Laws by Oasmia Pharmaceutical AB.
Investors who purchased shares of Oasmia Pharmaceutical AB (publ) (NASDAQ: OASM) have certain options and for certain investors are short and strict deadlines running. Deadline: September 27, 2019. NASDAQ: OASM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Investors in shares of Oasmia Pharmaceutical AB (pub …
An investigation was announced on behalf of investors of Oasmia Pharmaceutical AB (publ) (OASM) shares over potential securities laws violations by Oasmia Pharmaceutical AB.
Investors who purchased shares of Oasmia Pharmaceutical AB (publ) (NASDAQ: OASM), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Oasmia Pharmaceutical…
Pet Cancer Therapeutics Market Prominent Players – Zoetis, Merial, Aratana The …
Pet Cancer Therapeutics Market size to exceed USD 300 million by 2024, as per a new research report by Global Market Insights, Inc.
Growing pet adoption rate coupled with increasing disposable income of pet owners will drive pet cancer therapeutics market growth. Strong and robust drug pipeline for treatment of pet cancer will stimulate business growth over the forecast years.
Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/2017
High cost of pet…
Women Health Therapeutics Market Trends to 2023 Profiling Merck, Roche, Novo Nor …
MarketStudyReport.com adds New “Global Women Health Therapeutics Market by Manufacturers, Countries, Type and Application, Forecast to 2023” new report to its research database. The report spread across 121 pages with table and figures in it. The report provides information on Industry Trends, Demand, Top Manufacturers, Countries, Material and Application.
Women's experience of health and disease differ from those of men, due to unique biological, social and behavioural conditions. Biological differences vary…
